Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein degradation-based anti-infective drug research. | Acta Pharm Sin B | 2025 | 41311400 | PubTator, text mining | PubMed |
| Innovative Strategies for the Targeted Degradation of Viral Proteins: Paving the Way for Next-Generation Therapeutics. | Pharmaceutics | 2025 | 41304758 | PubTator, text mining | PubMed |
| GlueFinder: A Data-Driven Framework for the Rational Discovery of Molecular Glues. | bioRxiv | 2025 | 41279909 | PubTator, text mining | PubMed |
| Design of Tissue-Selective PROTACs Through Recruiting E3 Ligase Scaffolding Protein MAGEA11. | bioRxiv | 2025 | 41279184 | PubTator, text mining | PubMed |
| CDK4/6 Inhibition Reverses MEIS2 Suppression of CRL4 CRBN to Enhance Immunomodulatory Drug Therapy in Multiple Myeloma. | bioRxiv | 2025 | 41279046 | PubTator, text mining | PubMed |
| Design and evaluation of an HSP70-targeting PROTAC in synergy with an HSF1 inhibitor for enhanced antitumor activity. | RSC Med Chem | 2025 | 41262768 | PubTator, text mining | PubMed |
| PROTAC-PatentDB: A PROTAC Patent Compound Dataset. | Sci Data | 2025 | 41261151 | PubTator, text mining | PubMed |
| PSP-0119: Targeted IRAK4 Degradation as a Novel Therapeutic Strategy for FLT3-Mutant AML. | bioRxiv | 2025 | 41256437 | PubTator, text mining | PubMed |
| Discovery of CRBN-recruiting PROTAC degraders of the METTL3-METTL14 complex. | Med Chem Res | 2025 | 41245600 | PubTator, text mining | PubMed |
| Nuclear Magnetic Resonance-based fragment screen of the E3 ligase Fem-1 homolog B. | Protein Sci | 2025 | 41229306 | PubTator, text mining | PubMed |
| PROTAC repurposing uncovers a noncanonical binding surface that mediates chemical degradation of nuclear receptors. | Nat Commun | 2025 | 41198675 | PubTator, text mining | PubMed |
| Mezigdomide for multiple myeloma: a focus on phase 2 trial data. | Expert Opin Emerg Drugs | 2025 | 41163399 | PubTator, text mining | PubMed |
| Small-molecule degron mimetics for targeted protein degradation. | Essays Biochem | 2025 | 41124365 | PubTator, text mining | PubMed |
| Cysteine-reactive covalent chloro-N-acetamide ligands induce ferroptosis mediated cell death. | EMBO Rep | 2025 | 41102521 | PubTator, text mining | PubMed |
| Epigenetic regulation of Cereblon in cancer: molecular mechanisms and clinical implications. | Genes Genomics | 2025 | 41091304 | PubTator, text mining | PubMed |
| Targeted Histone Deacetylase Degradation via Chemical Induced Proximity by Direct Recruitment of the CUL4 Complex Adaptor Protein DDB1. | ACS Med Chem Lett | 2025 | 41089485 | PubTator, text mining | PubMed |
| Unsupervised multiscale clustering of single-cell transcriptomes to identify hierarchical structures of cell subtypes. | Gigascience | 2025 | 41066207 | PubTator, text mining | PubMed |
| Discovery and Characterization of Novel IKZF1/3 Glue Degraders against Multiple Hematological Cancer Cell Lines. | Oncol Res | 2025 | 41050081 | PubTator, text mining | PubMed |
| Dual Targeting of IKKβ and NR4A1 for AML Therapy. | bioRxiv | 2025 | 41040298 | PubTator, text mining | PubMed |
| GSPT1 degraders: research progress, development strategies and challenges. | Bioorg Med Chem | 2025 | 41004880 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=10